Pricing Log in Create free account

Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) vs NKGen Biotech, Inc. (NKGN)

Chemomab Therapeutics Ltd. Sponsored ADR and NKGen Biotech, Inc. are both Biotechnology companies. Chemomab Therapeutics Ltd. Sponsored ADR and NKGen Biotech, Inc. are of similar size ($9.4M and $8.8M). Across the 9 metrics below, NKGen Biotech, Inc. leads on 5 and Chemomab Therapeutics Ltd. Sponsored ADR on 4.

Valuation

Metric CMMB NKGN Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 1.17 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (63.03%) (10,600.00%) (33.15%)
Free cash flow yield (358.23%) (4,296.38%) (25.50%)

Profitability

Metric CMMB NKGN Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (82.17%) 44.70% (56.36%)
Return on assets (70.70%) (146.49%) (48.04%)
Return on invested capital (247.40%) 0.00% 0.00%

Growth

Metric CMMB NKGN Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 58.14% 71.38% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CMMB NKGN Biotechnology median
Debt to equity 0.00 (0.59) 0.00
Current ratio 6.41 0.05 4.72
Net debt to EBITDA 1.09 (1.69) 0.96

Dividend

Metric CMMB NKGN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CMMB NKGN Biotechnology median
Market cap 9.35m 8.76m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack